Search Results - "Bela Sarmento‐Ribeiro, Ana"
-
1
Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia—From Molecular Mechanisms to Clinical Relevance
Published in Cancers (26-09-2021)“…Resistance to targeted therapies is a complex and multifactorial process that culminates in the selection of a cancer clone with the ability to evade…”
Get full text
Journal Article -
2
Bone marrow follicular‐like T cells in monoclonal gammopathies
Published in Cytometry. Part B, Clinical cytometry (01-01-2022)Get full text
Journal Article -
3
CD20+ T cells in monoclonal B cell lymphocytosis and chronic lymphocytic leukemia: frequency, phenotype and association with disease progression
Published in Frontiers in oncology (28-03-2024)“…In monoclonal B cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL), the expansion of malignant B cells disrupts the normal homeostasis and…”
Get full text
Journal Article -
4
DNA Methylation Is Correlated with Oxidative Stress in Myelodysplastic Syndrome—Relevance as Complementary Prognostic Biomarkers
Published in Cancers (23-06-2021)“…Oxidative stress and abnormal DNA methylation have been implicated in cancer, including myelodysplastic syndromes (MDSs). This fact leads us to investigate…”
Get full text
Journal Article -
5
CD43 and CD49d from the B‐Cell Chronic Lymphoproliferative Disorders Diagnostic Panel Are Useful to Detect Erythroid Dysplasia
Published in Cytometry. Part B, Clinical cytometry (01-09-2019)“…Background Despite bone marrow (BM) immunophenotyping by flow cytometry has progressively been recognized as an important tool for the diagnosis of…”
Get full text
Journal Article -
6
PB1822: INHIBITION OF THE DNA DAMAGE RESPONSE: A POSSIBLE NEW ROUTE IN ACUTE MYELOBLASTIC LEUKEMIA TREATMENT
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
7
PB1841: NUCLEOLIN INTERACTS WITH NUCLEOPHOSMIN AS A PREDICTOR OF PROGNOSIS IN ACUTE MYELOBLASTIC LEUKEMIA
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
8
P659: BUPARLISIB A PROMISING THERAPEUTIC APPROACH IN CHRONIC MYELOID LEUKEMIA RESISTANT TO IMATINIB
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
9
PB1719: NIRAPARIB IN B‐CELL LYMPHOID MALIGNANCIES: EXPLORING SYNTHETIC LETHALITY AS TARGET FOR THERAPY
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
10
-
11
P841: MOLECULAR MECHANISMS OF RESISTANCE TO IMMUNOMODULATORS IN MULTIPLE MYELOMA: AN IN VITRO STUDY
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
12
Genetic variants involved in oxidative stress, base excision repair, DNA methylation, and folate metabolism pathways influence myeloid neoplasias susceptibility and prognosis
Published in Molecular carcinogenesis (01-01-2017)“…Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) share common features: elevated oxidative stress, DNA repair deficiency, and aberrant DNA…”
Get full text
Journal Article -
13
Zinc: From Biological Functions to Therapeutic Potential
Published in International journal of molecular sciences (02-03-2023)“…The trace element zinc (Zn) displays a wide range of biological functions. Zn ions control intercellular communication and intracellular events that maintain…”
Get full text
Journal Article -
14
The multi-factorial nature of clinical multidrug resistance in cancer
Published in Drug resistance updates (01-09-2019)“…Curative cancer therapy remains a major challenge particularly in cancers displaying multidrug resistance (MDR). The MDR phenotype is characterized by…”
Get full text
Journal Article -
15
Effects of X-radiation on lung cancer cells: the interplay between oxidative stress and P53 levels
Published in Medical oncology (Northwood, London, England) (01-12-2015)“…Lung cancer (LC) ranks as the most prevalent and deadliest cause of cancer death worldwide. Treatment options include surgery, chemotherapy and/or…”
Get full text
Journal Article -
16
Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies
Published in Drug resistance updates (01-12-2020)“…Cancer is one of the main public health problems in the world. Systemic therapies such as chemotherapy and more recently target therapies as well as…”
Get full text
Journal Article -
17
The emergence of drug resistance to targeted cancer therapies: Clinical evidence
Published in Drug resistance updates (01-12-2019)“…For many decades classical anti-tumor therapies included chemotherapy, radiation and surgery; however, in the last two decades, following the identification of…”
Get full text
Journal Article -
18
Advancements in Biomarkers and Molecular Targets in Hematological Neoplasias
Published in International journal of molecular sciences (01-06-2024)“…Hematological neoplasias are among the most common cancers worldwide, and the number of new cases has been on the rise since 1990, reaching 1 [...]…”
Get full text
Journal Article -
19
Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies
Published in International journal of molecular sciences (23-05-2023)“…Lymphoid malignancies are a group of highly heterogeneous diseases frequently associated with constitutive activation of the nuclear factor kappa B (NF-κB)…”
Get full text
Journal Article -
20
Epithelial‐mesenchymal transition and microRNAs: Challenges and future perspectives in oral cancer
Published in Head & neck (01-10-2018)“…Background Head and neck cancer is the sixth most common cancer worldwide, with oral squamous cell carcinoma (OSCC) being the most representative type. OSCC is…”
Get full text
Journal Article